Adenocarcinoma of the Pancreas Completed Phase 1 / 2 Trials for Gemcitabine (DB00441)

Also known as: Adenocarcinoma, Pancreatic / Adenocarcinoma of Pancreas / Pancreas Adenocarcinoma / Adenocarcinoma, Pancreas / Pancreatic Adenocarcinoma / Pancreas, Adenocarcinoma / Adenocarcinoma Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02037230Dose Escalation Trial of AZD1775 and Gemcitabine (+Radiation) for Unresectable Adenocarcinoma of the PancreasTreatment
NCT01064622Gemcitabine Hydrochloride With or Without Vismodegib in Treating Patients With Recurrent or Metastatic Pancreatic CancerTreatment
NCT00630552QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic CancerTreatment
NCT03451773M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the PancreasTreatment
NCT01016483Trial of Gemcitabine With or Without MSC1936369B in Pancreatic CancerTreatment
NCT00154791Phase I/II Trial GOFL in Advanced Pancreatic AdenocarcinomaTreatment